Geneva Health Forum 2012 Participation Report
date : 4/20/2012
The Geneva Health Forum 2012 was held from the 18-20 April, through cooperation between Geneva University Hospital, Geneva University Faculty of Medicine, and the Swiss Development Cooperation Agency (SDC).
Held since 2006, this latest fourth session was titled ‘A Critical Shift to Chronic Conditions: Learning From the Frontliners’, with discussion being conducted around the theme of non-communicable diseases (NCD), a joint agenda held by both high-income and low-income countries alike.
NCD became the agenda for the U.N. High Level Meeting held in September 2011, however what with this year set to see the determination of an international monitoring hub and goals, the main theme of this forum concerned in what way international cooperation and strategy at the country level should be executed.
On the third day of this forum, HGPI Director Ryoji Noritake also participated as a panelist in the session ‘National & Global Non-Communicable Diseases Platforms: The Best Way Forward’ (20 April, 12:30-14:00). Other panelists included Samantha Battams (Global Health Europe, Global Health Programme, Graduate Institute of International and Development Studies, Geneva, Switzerland), Gaudenz Silberschmidt (International Affairs Division, Swiss Federal Office of Public Health, Bern, Switzerland), Judith Watt (NCD Alliance, London, UK), Olivier Raynaud (World Economic Forum, Geneva, Switzerland), and Ruth Veale (Environment and Safety Department, BEUC [the European Consumers’ Organisation], Brussels, Belgium).
In this session, the importance of bottom-up activities by multi-stakeholders in individual countries together with global cooperation was highlighted in relation to tackling NCD. HGPI’s Ryoji Noritake introduced the directionality for NCD control in accordance with Japan’s re-adjusted local health care plans, and commented on the importance of each country achieving progress through breaking down NCD control into the form of concrete policies, as well as setting global targets.
Finally, it was noted that the NCD issue does not just concern medicine and healthcare but is also an economic and environmental problem. The forum concluded with recognition of the importance and necessity of cooperation and participation from other government agencies concerning the environment, industry and education, in approaching large shared goals.
Held since 2006, this latest fourth session was titled ‘A Critical Shift to Chronic Conditions: Learning From the Frontliners’, with discussion being conducted around the theme of non-communicable diseases (NCD), a joint agenda held by both high-income and low-income countries alike.
NCD became the agenda for the U.N. High Level Meeting held in September 2011, however what with this year set to see the determination of an international monitoring hub and goals, the main theme of this forum concerned in what way international cooperation and strategy at the country level should be executed.
On the third day of this forum, HGPI Director Ryoji Noritake also participated as a panelist in the session ‘National & Global Non-Communicable Diseases Platforms: The Best Way Forward’ (20 April, 12:30-14:00). Other panelists included Samantha Battams (Global Health Europe, Global Health Programme, Graduate Institute of International and Development Studies, Geneva, Switzerland), Gaudenz Silberschmidt (International Affairs Division, Swiss Federal Office of Public Health, Bern, Switzerland), Judith Watt (NCD Alliance, London, UK), Olivier Raynaud (World Economic Forum, Geneva, Switzerland), and Ruth Veale (Environment and Safety Department, BEUC [the European Consumers’ Organisation], Brussels, Belgium).
In this session, the importance of bottom-up activities by multi-stakeholders in individual countries together with global cooperation was highlighted in relation to tackling NCD. HGPI’s Ryoji Noritake introduced the directionality for NCD control in accordance with Japan’s re-adjusted local health care plans, and commented on the importance of each country achieving progress through breaking down NCD control into the form of concrete policies, as well as setting global targets.
Finally, it was noted that the NCD issue does not just concern medicine and healthcare but is also an economic and environmental problem. The forum concluded with recognition of the importance and necessity of cooperation and participation from other government agencies concerning the environment, industry and education, in approaching large shared goals.
Exhibition date：2012-04-20
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
![[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_eyecatch_20260619_AMR_Recommendations.png)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
![[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_2nd_eyecatch_web.jpg)
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
![[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260722_PLH-Academy-2.png)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
![[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/ckd-ncd-20260731-top_ENG.png)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)
![[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260930_The4th-J-PEPseminar.jpg)
